Caffeine inhibitors of MTHFD2 and uses thereof
US12187728B2 · kind B2 · utility
0Cited by
12References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2022 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Mar 6, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.